The next chapter: Changing market dynamics in commercialisation and medical communications

The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’.

As we move further into 2021 and further away from the worst effects of the pandemic, attention is turning to what the next phase in the sector’s evolution may bring. Are there visible risks to the high growth that the sector has recently enjoyed? Will we see continued consolidation and high valuations? Will the growth of digital channels stall as restrictions ease and events shift from virtual to in-person?

Join us for a short, 1-hour webinar on Wednesday, 21st April at 3pm (BST) 10am (ET – NY), as we interview an expert panel including Neil Jones, COO at Huntsworth; Dr Jill Harrison, Executive Director at Bioscript Group and Martin Ellis, Founder of Medicom Group and former Non-Executive Chair at Havas Life Medicom, who have all kindly agreed to share their insights on the next chapter for the sector.

This event is designed for business owners, investors and executives in the commercialisation sector. Spaces are limited so please register today.